# Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation

**Authors:** Qiang Zhang, Xinqiao Tang, Zhong Liu, Xiaoxia Song, Dan Peng, Wei Zhu, Zhengxiao Ouyang, Wanchun Wang

PMC · DOI: 10.3389/fphar.2025.1678215 · Frontiers in Pharmacology · 2026-01-07

## Full-text entities

- **Genes:** IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}
- **Chemicals:** Hesperetin (MESH:C013015)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12820524/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12820524/full.md

---
Source: https://tomesphere.com/paper/PMC12820524